Dake, Michael D.
Fanelli, Fabrizio
Lottes, Aaron E.
O’Leary, Erin E.
Reichert, Heidi
Jiang, Xiaohui
Fu, Weiguo
Iida, Osamu
Zen, Kan
Schermerhorn, Marc
Zeller, Thomas
Ansel, Gary M.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
https://doi.org/10.1007/s00270-020-02648-6
Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery
https://doi.org/10.1016/j.jvs.2014.01.041
Documents that mention this clinical trial
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
https://doi.org/10.1007/s00270-020-02648-6
Documents that mention this clinical trial
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
https://doi.org/10.1007/s00270-020-02648-6
Documents that mention this clinical trial
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
https://doi.org/10.1007/s00270-020-02648-6
Documents that mention this clinical trial
Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
https://doi.org/10.1007/s00270-020-02648-6
Funding for this research was provided by:
Cook Medical
Article History
Received: 4 August 2020
Accepted: 8 September 2020
First Online: 6 October 2020
Compliance with Ethical Standards
:
: MDD, AEL, HR, XJ, and GMA are paid consultants for Cook Medical. FF is a paid consultant for Cook. Medtronic, Volcano, Philips, WL Gore & Associates. EEO’L is a paid employee of Cook Medical. MS is a paid consultant for Abbott, Endologix, and Medtronic. TZ has received honoraria from Abbott Vascular, Veryan, Biotronik, Boston Scientific Corp., Cook Medical, Gore & Associates, Medtronic, Philips-Spectranetics, Shockwave; consulted for Boston Scientific Corp., Gore & Associates, Medtronic, Veryan, Intact Vascular, Shockwave, Bayer, Vesper Medical; received (institution) research, clinical trial, or drug study funds from 480 biomedical, Bard Peripheral Vascular, Veryan, Biotronik, Efemoral, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, B. Braun; and has common stock in QT Medical. WF, OI, and KZ report no relevant conflicts to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: For the Zilver PTX randomized controlled trial (RCT), single-arm study (SAS), the China study, and the US post-approval study (US PAS), informed consent was obtained from all individual participants included in the study. For the Japan post-market surveillance study, informed consent processes were determined by each institution’s ethical committee policy to specify whether informed consent was necessary or outcome data could be abstracted while protecting patients’ rights without requiring individual patient consent.